GFG Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-229
Closed -$35K 203
2025
Q2
$35K Buy
+229
New +$35.2K 0.01% 126
2023
Q2
Sell
-998
Closed -$458K 120
2023
Q1
$458K Sell
998
-1,597
-62% -$258K 0.1% 69
2022
Q4
$458K Sell
2,595
-83
-3% -$14.3K 0.07% 72
2022
Q3
$437K Sell
2,678
-1
-0% -$169 0.14% 72
2022
Q2
$476K Sell
2,679
-340
-11% -$60.6K 0.15% 71
2022
Q1
$535K Sell
3,019
-6,973
-70% -$1.19M 0.16% 79
2021
Q4
$1.71M Buy
9,992
+379
+4% +$62K 0.51% 38
2021
Q3
$1.55M Sell
9,613
-251
-3% -$42.8K 0.49% 39
2021
Q2
$1.63M Buy
9,864
+781
+9% +$129K 0.49% 34
2021
Q1
$1.49M Buy
9,083
+1,490
+20% +$241K 0.52% 33
2020
Q4
$1.2M Buy
7,593
+1,816
+31% +$268K 0.39% 39
2020
Q3
$860K Buy
5,777
+972
+20% +$144K 0.33% 44
2020
Q2
$676K Buy
+4,805
New +$700K 0.29% 51

Other funds holding JNJ

GFG Capital's JNJ Position: Q3 2025 in Review

GFG Capital sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 229 shares — an estimated $35K sold.

GFG Capital first reported a position in JNJ in Q2 2020 and held it in 13 quarters. The position peaked at $1.71M in Q4 2021. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • GFG Capital reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • GFG Capital sold 229 Johnson & Johnson shares in Q3 2025, an estimated $35K.
  • GFG Capital first reported a position in Johnson & Johnson in Q2 2020 and held it in 13 quarters.
  • GFG Capital's Johnson & Johnson position peaked at $1.71M in Q4 2021.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.